Search Results

As it shifts focus to a death receptor 3 (DR3) antagonist antibody, Shattuck Labs is cutting a significant number of employees before the end of the year.

SomaLogic Operating Co. Inc., today announced its partnership with Dante Genomics to offer a comprehensive solution for proteomics testing at scale in Europe.

Dante Labs , a global leader in genomic information and precision medicine, announces new genomic driven biosimulation and significant progress made to its drug discovery program, demonstrating the value of the Dante Platform.

Dante Labs today announced the expansion of its Dante 30X Whole Genome Sequencing Test with personalized interpretation leveraging Dante’s proprietary Extensa Software Platform.

Dante Labs today announced the launch of Dante Genomics, an online marketplace portal specifically dedicated to healthcare providers, clinics, researchers and governments which will offer advanced genomic services for research and clinical applications.

Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today announced further interim results from a clinical research study that assessed the accuracy of Know Labs’ proprietary non-invasive radiofrequency (RF) dielectric sensor in measuring blood glucose.

Know Labs, Inc. today announced the appointment of Chris Somogyi as President, International.

Hypha Labs, Inc. (OTC Pink:DIGP) has announced that it has made Craig Ellins its Chief Science Officer. Hypha Labs, Inc. changed its name from Digipath, Inc. after the sale of its cannabis lab assets.

Dante Genomics, a global leader in genomics and precision medicine, today announced a free, initial feature of its platform agnostic proprietary B2B software to automatically turn FASTQ files to VCF files at no charge as an introduction to its AVANTI Software, demonstrating the broad scalability of its interpretation software to benefit sequencing labs of all sizes around the world.

Multiply Labs and Portal Biotechnologies announced their collaboration today, combining the efficiency of Multiply Labs’ robotic automation with the differentiated cell engineering capabilities of the Portal platform.